Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.350
+0.050 (3.85%)
At close: Sep 14, 2026, 4:00 PM EDT
1.340
-0.010 (-0.74%)
After-hours: Sep 14, 2026, 7:48 PM EDT
PACB Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 11, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Maintains $1.5 → $1.35 | Hold | Maintains | $1.5 → $1.35 | n/a | Sep 9, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 | Hold | Reiterates | $2 | +48.15% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $3 | Buy | Maintains | $3 | +122.22% | Aug 6, 2026 |
| Barclays | Barclays | Sell Maintains $1.25 | Sell | Maintains | $1.25 | -7.41% | Aug 5, 2026 |